These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36339889)

  • 1. Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation.
    Al-Seykal I; Bose A; Chevli PA; Hashmath Z; Sharma N; Mishra AK; Laidlaw D
    World J Cardiol; 2022 Oct; 14(10):537-545. PubMed ID: 36339889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin Angiotenin Blocker Pre-treatment and Recurrence After Pulmonary Vein Isolation in Patients with Paroxysmal and Persistent Atrial Fibrillation.
    Rosen BD; Akoum N; Burgon N; Vergara G; Marrouche N; Bader F
    J Atr Fibrillation; 2013; 6(3):898. PubMed ID: 28496891
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction.
    Mohanty S; Mohanty P; Trivedi C; Gianni C; Bai R; Burkhardt JD; Gallinghouse JG; Horton R; Sanchez JE; Hranitzky PM; Al-Ahmad A; Bailey S; Di Biase L; Natale A
    Heart Rhythm; 2015 Sep; 12(9):1963-71. PubMed ID: 26051531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers on patients following ablation of atrial fibrillation.
    Park JH; Oh YS; Kim JH; Chung WB; Oh SS; Lee DH; Choi YS; Shin WS; Park CS; Youn HJ; Chung WS; Lee MY; Seung KB; Rho TH; Kim JH; Hong SJ
    Korean Circ J; 2009 May; 39(5):185-9. PubMed ID: 19949577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
    Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a left common pulmonary vein and pulmonary vein anatomical characteristics as predictors of outcome following cryoballoon ablation for paroxysmal atrial fibrillation.
    Bose A; Chevli PA; Berberian G; Januszkiewicz J; Ahmad G; Hashmath Z; Mishra AK; Laidlaw D
    J Interv Card Electrophysiol; 2021 Nov; 62(2):409-417. PubMed ID: 33206281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of renin-angiotensin-aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension.
    Xu W; Yang YM; Zhu J; Wu S; Wang J; Zhang H; Shao XH
    BMC Cardiovasc Disord; 2022 Apr; 22(1):141. PubMed ID: 35365067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation.
    Wang X; Song B; Qiu C; Han Z; Wang X; Lu W; Chen X; Chen Y; Pan L; Sun G; Qin X; Li R
    Clin Cardiol; 2021 Jan; 44(1):78-84. PubMed ID: 33205849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
    White CM; Kluger J; Lertsburapa K; Faheem O; Coleman CI
    Eur J Cardiothorac Surg; 2007 May; 31(5):817-20. PubMed ID: 17350856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
    Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation.
    Hoffmann E; Straube F; Wegscheider K; Kuniss M; Andresen D; Wu LQ; Tebbenjohanns J; Noelker G; Tilz RR; Chun JKR; Franke A; Stellbrink C; Garcia-Alberola A; Dorwarth U; Metzner A; Ouarrak T; Brachmann J; Kuck KH; Senges J;
    Europace; 2019 Sep; 21(9):1313-1324. PubMed ID: 31199860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
    Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
    Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
    Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M
    J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.
    Ozawa T; Hashiguchi Y; Yagi T; Fukushima Y; Shimada R; Hayama T; Tsuchiya T; Nozawa K; Iinuma H; Ishihara S; Matsuda K
    Int J Colorectal Dis; 2019 Oct; 34(10):1731-1739. PubMed ID: 31478086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
    Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel risk model for very late return of atrial fibrillation beyond 1 year after cryoballoon ablation: the SCALE-CryoAF score.
    Peigh G; Kaplan RM; Bavishi A; Diaz CL; Baman JR; Matiasz R; Trivedi A; Sattayaprasert P; Wasserlauf J; Shen MJ; Potpara TS; Chicos AB; Arora R; Kim S; Lin A; Verma N; Knight BP; Passman RS
    J Interv Card Electrophysiol; 2020 Aug; 58(2):209-217. PubMed ID: 31327104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.